LENVATINIB
Clinical trials for LENVATINIB explained in plain language.
Never miss a new study
Get alerted when new LENVATINIB trials appear
Sign up with your email to follow new studies for LENVATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major study tracks 2500 liver cancer patients on new drugs
Disease control OngoingThis study is looking back at how well newer drug treatments work for people with liver cancer. Researchers are reviewing the medical records of 2500 patients who received treatments like Keytruda, Tecentriq, and Lenvatinib between 2019 and 2024. The goal is to understand if thes…
Matched conditions: LENVATINIB
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Three-Drug attack before surgery aims to stop deadly liver Cancer's return
Disease control OngoingThis study is testing a new three-drug combination given before surgery for a type of aggressive liver cancer called intrahepatic cholangiocarcinoma. The goal is to shrink tumors and lower the very high chance of the cancer coming back after surgery. Researchers will compare this…
Matched conditions: LENVATINIB
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC